Stockreport

Larimar Therapeutics to Participate in Upcoming Investor Conferences in March

Larimar Therapeutics, Inc.  (LRMR) 
PDF BALA CYNWYD, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing [Read more]